Bokus

Peter J. Neumann – författare

Visar alla böcker från författaren Peter J. Neumann. Handla med fri frakt och snabb leverans.

7 produkter

  1. Peter J. Neumann, Theodore G. Ganiats, Louise B. Russell, Gillian D. Sanders, Joanna E. Siegel - Cost-Effectiveness in Health and Medicine, Inbunden. Tillgänglighet: Lägg i varukorg

    Cost-Effectiveness in Health and Medicine

    Av Peter J. Neumann, Theodore G. Ganiats m. fl.

    Inbunden, 2016

    1261 kr

    Lägg i varukorg

    A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT"At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." --American Journal of Preventive Medicine Twenty years after the first edition of COST-EFFECTIVENESS IN HEALTH AND MEDICINE …

  2. Theodore G. Ganiats, Joanna E. Siegel, Louise B. Russell, Gillian D. Sanders, Peter J. Neumann - Cost-Effectiveness in Health and Medicine, E-bok. Tillgänglighet: Lägg i varukorg

    Cost-Effectiveness in Health and Medicine

    Av Theodore G. Ganiats, Joanna E. Siegel m. fl.

    E-bok, 2016

    680 kr

    Lägg i varukorg

    A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT "At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." -- American Journal of Preventive Medicine Twenty years after the first edition of COST-EFFECTIVENESS IN HEALTH AND …

  3. Theodore G. Ganiats, Joanna E. Siegel, Louise B. Russell, Gillian D. Sanders, Peter J. Neumann - Cost-Effectiveness in Health and Medicine, E-bok. Tillgänglighet: Lägg i varukorg

    Cost-Effectiveness in Health and Medicine

    Av Theodore G. Ganiats, Joanna E. Siegel m. fl.

    E-bok, 2016

    680 kr

    Lägg i varukorg

    A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT "At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." -- American Journal of Preventive Medicine Twenty years after the first edition of COST-EFFECTIVENESS IN HEALTH AND …

  4. Peter J. Neumann, Joshua T. Cohen, Daniel A. Ollendorf - The Right Price, Häftad. Tillgänglighet: Lägg i varukorg

    The Right Price

    A Value-Based Prescription for Drug Costs

    Av Peter J. Neumann, Joshua T. Cohen m. fl.

    Häftad, 2021

    796 kr

    Lägg i varukorg

    The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in …

  5. Peter J. Neumann, Joshua T. Cohen, Daniel A. Ollendorf - The Right Price, Inbunden. Tillgänglighet: Lägg i varukorg

    The Right Price

    A Value-Based Prescription for Drug Costs

    Av Peter J. Neumann, Joshua T. Cohen m. fl.

    Inbunden, 2021

    1551 kr

    Lägg i varukorg

    The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in …

  6. Daniel A. Ollendorf, Joshua T. Cohen, Peter J. Neumann - Right Price, E-bok. Tillgänglighet: Lägg i varukorg

    Right Price

    A Value-Based Prescription for Drug Costs

    Av Daniel A. Ollendorf, Joshua T. Cohen m. fl.

    E-bok, 2021

    491 kr

    Lägg i varukorg

    The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in …

  7. Daniel A. Ollendorf, Joshua T. Cohen, Peter J. Neumann - Right Price, E-bok. Tillgänglighet: Lägg i varukorg

    Right Price

    A Value-Based Prescription for Drug Costs

    Av Daniel A. Ollendorf, Joshua T. Cohen m. fl.

    E-bok, 2021

    491 kr

    Lägg i varukorg

    The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in …